We are live on ! Find out more
KNTE

Kinnate Biopharma Inc. Common Stock
KNTE

Delisted

KNTE was delisted on the 2nd of April, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of KNTE yet.

KNTE Hedge Fund Activity: Q2 2024 in Review

0 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Kinnate Biopharma Inc. Common Stock (KNTE) for Q2 2024, worth a combined $0 — down 100% from $92.2M a quarter earlier.

Sellers outnumbered buyers: 56 funds closed out of KNTE and 0 opened new positions — a net loss of 56 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Foresite Capital Management IV, exiting entirely with an estimated $25.7M sold.

  • 0 institutional investors held Kinnate Biopharma Inc. Common Stock (KNTE) as of Q2 2024, down from 56 in Q1 2024.
  • Funds reported $0 of Kinnate Biopharma Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Kinnate Biopharma Inc. Common Stock positions in Q2 2024 and 56 closed out, a net change of -56 holders.
  • The largest Kinnate Biopharma Inc. Common Stock seller in Q2 2024 was Foresite Capital Management IV, an estimated $25.7M sold.

Based on aggregated 13F filings for Q2 2024.